This interactive enduring activity is designed to educate healthcare professionals on the evidence-based implementation of immune checkpoint inhibitors into the management of patients with non-small cell lung cancer (NSCLC). A special emphasis will be placed on how to optimize care across a multidisciplinary and community-based oncology care team, using a patient-centered approach augmented by shared decision-making practices.

RELEASED DATE: December 20, 2024
EXPIRATION DATE: December 20, 2025

With multiple immunotherapy-based treatment options available for the frontline treatment of advanced/metastatic non-small cell lung cancer (NSCLC), clinicians require updates that inform individualized treatment planning. This interactive multicomponent program provides a review of current evidence-based guidelines and clinical data, including recent updates presented at ASCO, regarding optimal use of immune checkpoint inhibition for metastatic NSCLC. The array of resources and tools offered will help you use best practices in your clinical practice that incorporate shared decision-making and the multidisciplinary team.

RELEASED DATE: July 31, 2025
EXPIRATION DATE: July 31, 2026